Detalhe da pesquisa
1.
Immune Responses to a Single Dose of the AZD1222/Covishield Vaccine at 16 Weeks in Individuals in Sri Lanka.
J Immunol
; 207(11): 2681-2687, 2021 12 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-34750205
2.
Immune responses to Sinopharm/BBIBP-CorV in individuals in Sri Lanka.
Immunology
; 167(2): 275-285, 2022 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-35758860
3.
Comparison of the immunogenicity of five COVID-19 vaccines in Sri Lanka.
Immunology
; 167(2): 263-274, 2022 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-35751563
4.
Kinetics of immune responses to SARS-CoV-2 proteins in individuals with varying severity of infection and following a single dose of the AZD1222.
Clin Exp Immunol
; 208(3): 323-331, 2022 06 23.
Artigo
em Inglês
| MEDLINE | ID: mdl-35641142
5.
Regulatory T-cells in acute dengue viral infection.
Immunology
; 154(1): 89-97, 2018 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-29140541
6.
Dengue NS1 antigen as a marker of severe clinical disease.
BMC Infect Dis
; 14: 570, 2014 Oct 31.
Artigo
em Inglês
| MEDLINE | ID: mdl-25366086
7.
Comparison of the kinetics and magnitude of antibody responses to different SARS-CoV-2 proteins in Sinopharm/BBIBP-CorV vaccinees following the BNT162b2 booster or natural infection.
PLoS One
; 17(10): e0274845, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-36227884
8.
Dengue virus co-opts innate type 2 pathways to escape early control of viral replication.
Commun Biol
; 5(1): 735, 2022 07 22.
Artigo
em Inglês
| MEDLINE | ID: mdl-35869167
9.
Antibody responses to Sinopharm/BBIBP-CorV in pregnant mothers in Sri Lanka.
PLOS Glob Public Health
; 2(7): e0000607, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-36962461
10.
Kinetics of immune responses to the AZD1222/Covishield vaccine with varying dose intervals in Sri Lankan individuals.
Immun Inflamm Dis
; 10(4): e592, 2022 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-35349749
11.
Immune responses following the first dose of the Sputnik V (Gam-COVID-Vac).
Sci Rep
; 12(1): 1727, 2022 02 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-35110645
12.
Persistence of immune responses to the Sinopharm/BBIBP-CorV vaccine.
Immun Inflamm Dis
; 10(6): e621, 2022 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-35634958
13.
Comparison of two assays to detect IgG antibodies to the receptor binding domain of SARSCoV2 as a surrogate marker for assessing neutralizing antibodies in COVID-19 patients.
Int J Infect Dis
; 109: 85-89, 2021 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-34161801
14.
Kinetics of immune responses to the AZD1222/Covishield vaccine with varying dose intervals in Sri Lankan individuals.
medRxiv
; 2021 Oct 27.
Artigo
em Inglês
| MEDLINE | ID: mdl-34729569
15.
Immune responses to a single dose of the AZD1222/Covishield vaccine in health care workers.
Nat Commun
; 12(1): 4617, 2021 07 29.
Artigo
em Inglês
| MEDLINE | ID: mdl-34326317
16.
Persistence of antibody and T cell responses to the Sinopharm/BBIBP-CorV vaccine in Sri Lankan individuals.
medRxiv
; 2021 Oct 18.
Artigo
em Inglês
| MEDLINE | ID: mdl-34704105
17.
Altered monocyte response to the dengue virus in those with varying severity of past dengue infection.
Antiviral Res
; 169: 104554, 2019 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-31288040
18.
Ex Vivo ELISpot Assay to Investigate iNKT Cell Responses in Acute Dengue Infection.
Methods Mol Biol
; 1808: 181-186, 2018.
Artigo
em Inglês
| MEDLINE | ID: mdl-29956184
19.
Lipopolysaccharide acts synergistically with the dengue virus to induce monocyte production of platelet activating factor and other inflammatory mediators.
Antiviral Res
; 133: 183-90, 2016 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-27476044
20.
Functionality of dengue virus specific memory T cell responses in individuals who were hospitalized or who had mild or subclinical dengue infection.
PLoS Negl Trop Dis
; 9(4): e0003673, 2015 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-25875020